DEF: Amesite Inc. 2026 Annual Meeting Proxy Statement

Amesite Inc. has filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held on July 13, 2026.

Summary

• The Annual Meeting is scheduled for July 13, 2026, at 10:00 a.m. ET in a virtual format.
• Stockholders will vote on the election of two Class II Directors: Ann Marie Sastry and Barbie Brewer.
• The company seeks ratification of Novogradac & Company LLP as its independent registered public accounting firm for the fiscal year ending June 30, 2026.
• Approval is requested for an amendment to the 2018 Equity Incentive Plan to increase the share reserve by 1,000,000 shares.
• Stockholders are asked to approve the issuance of up to 2,787,464 shares of common stock upon the exercise of Series A-1 and Series A-2 warrants issued in a recent private placement.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a defensive filing focused on maintaining liquidity and securing shareholder approval for necessary capital-raising activities, reflecting ongoing financial pressure.

Positives

• The company has secured a private placement to raise capital, with potential for approximately $5.2 million in gross proceeds if warrants are exercised for cash.
• The board has taken steps to formalize corporate governance, including the adoption of a clawback policy and a related person transaction policy.
• The company is utilizing the SEC's 'Notice and Access' model to reduce printing and distribution costs.

Negatives

• The independent auditor's report for the fiscal year ended June 30, 2024, included an explanatory paragraph regarding the uncertainty of the company's ability to continue as a going concern.
• The company has experienced recent turnover in its board of directors and executive management team.
• Several directors and officers were late in filing required Section 16(a) ownership reports during the 2025 fiscal year.

Risks

• The company's ability to continue as a going concern remains a significant risk factor.
• Failure to obtain stockholder approval for the warrant exercise (Proposal 4) could result in the loss of approximately $5.2 million in potential funding.
• The company is dependent on its ability to attract and retain key personnel and service providers.
• The company's common stock is subject to volatility and potential delisting risks if it fails to meet Nasdaq listing requirements.

Future Outlook

The company is focused on continuing its operations and funding its business through the potential exercise of warrants and the utilization of its equity incentive plan to attract and retain talent.

Management Comments

• The board believes the current leadership structure, with Dr. Sastry serving as CEO and Chairman, is the most effective governance framework for the company at this time.
• Management urges stockholders to vote in favor of all proposals to ensure the presence of a quorum and to avoid the expenses of additional solicitation.

Industry Context

StockSavvy.ai notes that Amesite's reliance on equity-based compensation and warrant-heavy financing is characteristic of small-cap technology firms facing liquidity constraints and seeking to preserve cash while incentivizing staff.

Comparison to Industry Standards

• The company's use of a virtual-only meeting format is increasingly common among small-cap technology companies to reduce costs.
• The inclusion of a 'going concern' warning in the auditor's report is a significant red flag compared to established, profitable industry peers.
• The proposed increase in the equity incentive plan is a standard practice for growth-stage companies, though it may lead to further shareholder dilution.

Management Changes

Corporate Governance

Legal Proceedings

• None disclosed.

Related Party Transactions

• The company entered into a private placement with certain officers and directors, including Dr. Ann Marie Sastry and George Parmer, on April 27, 2026.

Stakeholder Impact

• Shareholders face potential dilution from the proposed increase in the equity incentive plan and the exercise of outstanding warrants.
• Employees and directors are eligible for equity awards under the 2018 Plan, aligning their interests with the company's growth.

Next Steps

• Hold the Annual Meeting of Stockholders on July 13, 2026.
• File a Form 8-K with the SEC within four business days after the meeting to report the final voting results.

Key Dates

Recommendation

The company is in a precarious financial position with a 'going concern' warning, making it a high-risk investment. While the warrant exercise provides a potential cash infusion, the ongoing dilution and financial uncertainty suggest a cautious 'hold' approach until the company demonstrates sustainable revenue growth.

Keywords

Amesite Inc, AMST, Proxy Statement, Equity Incentive Plan, Warrant Exercise, Corporate Governance, Nasdaq